Sweegen's Rebaudioside M receives full authorization for use in the United Kingdom
Bestevia Reb M expands sugar reduction solutions in the U.K.and is now available to food and beverage producers.
Rancho Santa Margarita, Calif., May 17, 2023 (GLOBE NEWSWIRE) -- Global sweetness and flavor innovator, Sweegen has announced that its Bestevia® Rebaudioside M (Reb M) has been fully authorized for use in the United Kingdom (U.K.) This regulatory approval marks a significant milestone for Sweegen, as it becomes the first and only company to receive authorization for any steviol glycosides produced using alternative technologies in the U.K.
Reb M, a high-purity steviol glycoside derived from the stevia plant, is renowned for its clean and sugar-like taste profile. It offers a natural, zero-calorie sweetness solution, making it an ideal choice for food and beverage manufacturers seeking to reduce sugar content and provide healthier options to consumers. Sweegen's nature-based sweeteners, including its Reb M, offer a scalable and cost-effective alternative to traditional sugar.
Brands in the U.K. have eagerly anticipated the authorization of Sweegen's Bestevia Reb M during the initial formulation phase and tastings. They are actively collaborating with Sweegen's food and beverage applications experts based at its EMEA U.K. Innovation Studio in Reading, England, to integrate this highly sought-after stevia ingredient, along with Sweegen's outstanding taste modulation and unique sweeteners, into their formulations.
Damian Bellusci, Vice President of Sales EMEA/APAC at Sweegen, expressed his excitement about the authorization, stating, "We are extremely proud to be the pioneers in securing full authorization for Bestevia Reb M in the U.K. This milestone reaffirms Sweegen's commitment to providing innovative, nature-based, and sustainable sweetening solutions to the industry. Reb M offers food and beverage manufacturers an exceptional tool to meet consumer demands for healthier products without compromising taste.”
The decision to authorize the bioconversion manufacturing method for steviol glycosides, including Reb M, was made by the Minister for Primary Care and Public Health in relation to England, the Welsh Ministers in relation to Wales, and the Minister for Public Health, Women's Health and Sport in relation to Scotland. The authorization is per Article 10(1) of retained Regulation 1333/2008, fulfilling the requirements.
The authorized manufacturing method allows for using steviol glycosides, including Reb M, in the Great Britain (GB) market. The Regulations provide updated terms of authorization for using this method in GB, with the terms being similar to those in the European Union (EU) and Northern Ireland. For the latest information, referring to the relevant EU Regulations on the EUR-Lex website is recommended.
Casey McCormick, Vice President of Global Innovation at Sweegen, emphasized the significance of Reb M in driving product innovation. “The approval of Bestevia Reb M in the UK represents a very positive step forward for brands looking to improve the nutrition profile of their products. The clean, sweet taste of our Bestevia Reb M enables new approaches to reduce and eliminate sugar in a way that exceeds consumers’ expectations and supports public health objectives to reduce sugar consumption.”
Hadi Omrani, Vice President of Technical and Regulatory Affairs at Sweegen, highlighted the rigorous safety and compliance standards behind Bestevia Reb M’s authorization. Omrani stated, “At Sweegen, we prioritize safety, quality, and regulatory compliance. Obtaining full authorization for Bestevia Reb M in the U.K. required thorough scientific evaluations and stringent assessments to ensure its safety for consumption. This achievement reflects our commitment to delivering superior products that meet the highest industry standards."
Sweegen is dedicated to revolutionizing the sweetener market with innovative solutions that promote healthier choices without compromising taste. The full authorization of Bestevia Reb M in the U.K. reinforces Sweegen's leadership in the nature-based sweetener space and positions the company as a trusted partner for food and beverage manufacturers worldwide.
Sweegen recently attained FEMA GRAS status for sweet proteins brazzein and thaumatin II, complementing steviol glycosides in food and beverage production. With the addition of brazzein and thaumatin II, Sweegen continues to expand its portfolio of safe and effective taste-modulating flavors that can help food and beverage manufacturers meet the demand for healthier and delicious products to align with consumers’ holistic approaches to wellness. Brazzein is the star ingredient in Sweegen's newly launched Sweetensify flavors for taste modulation, an ideal flavors tool for brands seeking to create sugar-like tastes in food and beverages.
Sweegen provides sweet-taste solutions for food and beverage manufacturers around the world.
We are on a mission to reduce sugar and artificial sweeteners in the global diet. Partnering with customers, we create delicious zero-sugar products that consumers love. With the best modern sweeteners in our portfolio, such as Bestevia® Rebs B, D, E, I, M, and N, and sweet proteins brazzein and thaumatin, along with our deep knowledge of flavor modulators and texturants, Sweegen delivers market-leading solutions that customers want, and consumers prefer. Well. Into the Future.
This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1996. Sweegen’s actual results may differ from the estimates, assumptions, and other illustrative material contained herein, and consequently, a reader should not rely on these forward-looking statements as predictions of future events. These forward-looking statements include, without limitation, illustrative information regarding Sweegen’s bottom-up assumed market potential, assumed hit rate, and the resulting revenue based on these model inputs. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
Industry, Market, and Other Data
In this press release, we rely on and refer to information and statistics regarding market participants in the sectors in which Sweegen competes and other data. We obtained this information and statistics from our own internal estimates and third-party sources, including reports by market research firms and company filings. We do not expressly refer to these sources. All of this information involves a number of assumptions and limitations, and the sources of such information cannot guarantee the accuracy or completeness of such information. The industry in which Sweegen operates is subject to a high degree of uncertainty and risk due to a variety of important factors, any of which could cause results to differ materially from those expressed in the estimates made by Sweegen or third parties.
Cautionary Statement Concerning Forward-Looking Statements
This press release contains forward-looking statements, including, among other statements, statements regarding the future prospects for Reb M stevia leaf sweetener, brazzein, and thaumatin. These statements are based on current expectations but are subject to certain risks and uncertainties, many of which are difficult to predict and beyond Sweegen's control.
Relevant risks and uncertainties could cause actual results to differ materially from those expressed in or implied by the forward-looking statements and, therefore, should be carefully considered. Sweegen assumes no obligation to update any forward-looking statements as a result of new information or future events or developments.
- Sweegen's Rebaudioside M receives full authorization for use in the United Kingdom
- Sweegen is dedicated to revolutionizing the sweetener market with innovative solutions that promote healthier choices without compromising taste.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Kallelse till årsstämma i Anoto Group AB (publ)1.6.2023 08:00:00 CEST | Pressemelding
Aktieägarna i Anoto Group AB (publ) (“Bolaget”), kallas härmed till årsstämma att äga rum fredagen den 30juni 2023kl. 10.00 i Setterwalls Advokatbyrås lokaler med adress Sturegatan 10 i Stockholm. Rätt att delta och anmälan Aktieägare som önskar att deltaga i årsstämman ska dels vara registrerad i eget namn i den av Euroclear Sweden AB förda aktieboken för Bolaget senast onsdagen den 21 juni 2023,dels anmäla sitt deltagande till Bolaget senast fredagen den 23 juni 2023. Anmälan om deltagande i årsstämman ska ske per telefon till +44 (0)758 4301260 eller via e-post till AGM@anoto.com. Vid anmälan ska namn, personnummer/organisationsnummer samt registrerat aktieinnehav uppges. Fullmakter, registreringsbevis och andra behörighetshandlingar bör för att underlätta inpasseringen vid stämman skickas till Bolaget via e-post till AGM@anoto.com senast fredagen den 23 juni 2023. Bolaget tillhandahåller fullmaktsformulär på Bolagets hemsida www.anoto.com. För att ha rätt att delta i stämman måste
Aegon completes sale of Central and Eastern European Businesses to VIG1.6.2023 08:00:00 CEST | Press release
The Hague, June 1, 2023 - Aegon today announces the completion of the divestment of its businesses in Poland and Romania to Vienna Insurance Group AG Wiener Versicherung Gruppe (VIG) for EUR 125 million. This was the final step to complete the full sale of Aegon’s insurance, pension and asset management business in Central and Eastern Europe to VIG, following the closings of the divestments of the Hungarian and Turkish businesses. “We are very pleased that we have now finalized the full divestment of our Central and Eastern European businesses. As part of Aegon’s transformation and sharpened focus, the closing allows us to fully concentrate on the countries and business lines where we can add most value, while our former businesses will start their new chapter as part of VIG,” says Lard Friese, CEO of Aegon. “I would like to sincerely thank our employees in Hungary, Poland, Romania and Turkey for their important contributions to Aegon over the years and I wish them all the best in thei
Notice to attend the Annual General Meeting in Anoto Group AB (publ)1.6.2023 08:00:00 CEST | Press release
The shareholders of Anoto Group AB (publ) (the “Company”) are hereby invited to attend the Annual General Meeting (the “AGM”) to be held on Friday30 June 2023 at 10 a.m. at the premises of SetterwallsAdvokatbyrå, Sturegatan 10 in Stockholm, Sweden. Notification of participation Shareholders wishing to attend the AGM must be entered as shareholders in the share register maintained by Euroclear Sweden AB no later than on Wednesday 21 June 2023,notify the Company of their intention to participate no later than on Friday 23 June 2023. Attendance is to be notified by phone to +44 (0)758 430 12 60 or by e-mail to AGM@anoto.com. The notification should state name, social security number/corporate identification number and registered number of shares. To facilitate admittance to the AGM, proxies, registration certificates and other authorisation documents should be submitted to the Company by email to AGM@anoto.com no later than on Friday 23 June 2023. The Company provides proxy forms on the C
Van Lanschot Kempen successfully issued €500 million Soft Bullet Covered Bond1.6.2023 08:00:00 CEST | Press release
Amsterdam/’s-Hertogenbosch, the Netherlands, 1 June 2023 31 May 2023, Van Lanschot Kempen successfully issued a €500 million 3 year Soft Bullet Covered Bond with a 3.5% fixed coupon. The deal had a final order book of €2 billion and was placed with a broad range of European institutional investors. The transaction further strengthens and diversifies Van Lanschot Kempen’s funding profile. The bonds are rated AAA by Standard & Poor’s. Van Lanschot Kempen’s Soft Bullet Covered Bond Programme is Dutch law-based and backed by a pool of Dutch residential mortgage loans. It is registered with De Nederlandsche Bank and is both UCITS-compliant and CRD-compliant. Van Lanschot Kempen mandated BNP Paribas, DZ Bank, ING, LBBW and Rabobank as Joint Lead Managers for this transaction. Media Relations: +31 20 354 45 85; firstname.lastname@example.org Investor Relations: +31 20 354 45 90; email@example.com About Van Lanschot Kempen Van Lanschot Kempen is an independent, spec
PGS - Mediterranean Contract Award1.6.2023 08:00:00 CEST | Press release
June 1, 2023, Oslo, Norway: PGS is awarded a 3D exploration acquisition contract in the Mediterranean by a major international energy company. Ramform Hyperion is expected to mobilize for the survey late third quarter and the program has a total duration of approximately 70 days. “We are very pleased with this contract award, which improves our visibility into the fourth quarter. There is increasing exploration interest in the Mediterranean following recent discoveries in this prolific gas province, and this award builds on our successful campaign from the previous season,” says President & CEO in PGS, Rune Olav Pedersen. PGS announces contract awards and MultiClient projects as stock exchange releases if the contract has a value of $10 million or more, MultiClient projects with a duration of 2 months or more and strategically important contracts. FOR DETAILS, CONTACT:Bård Stenberg, VP IR & Corporate Communication Mobile: +47 992 45 235 *** PGS ASA and its subsidiaries (“PGS” or “the C